<DOC>
	<DOCNO>NCT01219309</DOCNO>
	<brief_summary>Objective : To assess whether supplementation Omega 3/6 fatty acid ( eye q® ) effective treatment ADHD diagnostic subtypes comorbid condition , child adolescent . Method : Randomized placebo-controlled one-way crossover trial 75 child adolescent age 8-18 year receive Omega 3/6 placebo three month follow 3 month Omega 3/6 . ADHD symptom measure investigator-rated ADHD Rating Scale-IV-Parent Version Clinical Global Impression ( CGI ) scale symptom severity impairment .</brief_summary>
	<brief_title>Omega-3/Omega-6 Fatty Acids Attention-Deficit/Hyperactivity Disorder ( ADHD ) : A Trial Children Adolescents</brief_title>
	<detailed_description>The study design randomise , double-blind placebo-controlled trial total duration 6 month . 50-100 child adolescent , age 8-18 year , meet DSM-IVÔ criterion Attention-Deficit/Hyperactivity Disorder ( ADHD ) subtype give opportunity participate . The study comprise 2 study period . Study Period I This assessment/evaluation drug washout phase 1-3 month patient take medication exclude protocol . Study Period II Participants randomise 3 month treatment fix dose 6 capsule per day EyeQ , divide two daily dos , supply 558 mg EPA , 174 mg DHA 60 mg GLA daily , placebo . Identical capsule contain olive oil use placebo . Randomisation organize Equazen UK Ltd , prepare randomisation number send investigation centre . At 3 month one-way treatment crossover placebo-group active treatment make patient group receive EyeQ remain 3-month period . Compliance ascertain bi-weekly telephone contact visit . Compliance define take prescribed dosage &gt; 70 % day visit interval . Neuropsychiatric assessment : DSM IV checklist ADHD-Rating Scale IV - Parent : Inv Clinical Global Impression ( CGI ) scale GAF-scale FTF teacher questionnaire SNAP-IV teacher questionnaire Brown 's ADD teacher scale Neuropsychological assessment : WISC-III® WAIS-III® VMI Digit span Span-board task Qb-test Brown 's ADD self report CDI ( Children 's Depression Inventory ) Five Fifteen ( FTF ) parent questionnaire Brown 's ADD parent scale SNAP-IV parent questionnaire Nijmegen questionnaire HUFA deficiency questionnaire Reading writing test : DLS etc</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Attention Deficit Disorder Hyperactivity</mesh_term>
	<criteria>Patients age 818 year Met DSMIV criterion diagnosis ADHD subtype Autism Psychosis Bipolar disorder Mental retardation Uncontrolled seizure disorder Hyper hypothyroidism Significant medical condition Weight 20 kg Alcohol drug abuse use past three month psychoactive drug Omega 3 preparation</criteria>
	<gender>All</gender>
	<minimum_age>8 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>April 2010</verification_date>
	<keyword>Attention-deficit/hyperactivity disorder</keyword>
	<keyword>Omega 3/6 fatty acid</keyword>
	<keyword>Developmental coordination disorder</keyword>
	<keyword>Reading/writing difficulty .</keyword>
</DOC>